Currently out of the existing stock ratings of Dennis Ding, 9 are a BUY (75%), 3 are a HOLD (25%).

Dennis Ding

Work Performance Price Targets & Ratings Chart

Analyst Dennis Ding works at JEFFERIES with a stock forecast success ratio of 41.67% fulfilled within 23.67 days on average.

Dennis Ding’s has documented 22 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PRDS, Pardes Biosciences at 03-Apr-2023.

Wall Street Analyst Dennis Ding

Analyst best performing recommendations are on CINC (CINCOR PHARMA).
The best stock recommendation documented was for CINC (CINCOR PHARMA) at 11/30/2022. The price target of $12.3 was fulfilled within 1 day with a profit of $0.5 (4.24%) receiving and performance score of 42.37.

Average potential price target upside

ABUS Arbutus Biopharma Corp NGM NGM Biopharmaceuticals PRDS Pardes Biosciences ROIV Roivant Sciences Ltd CINC CinCor Pharma CORT Corcept Therapeutics orporated

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


5 months 14 days ago

0/3 (0%)

$3.1 (106.90%)


6 months 22 days ago

1/5 (20%)

$3.14 (109.79%)




7 months 20 days ago

0/1 (0%)

$2.9 (93.55%)



$2.09 (71.82%)

2 years 24 days ago

0/1 (0%)

$2.11 (73.01%)



2 years 7 months 29 days ago

0/2 (0%)

$3.7 (112.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Dennis Ding?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?